Pharmacodynamics of bardoxolone methyl. A, levels of NF- k B, cyclin... | Download Scientific Diagram
Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells | Molecular Pharmacology
Bardoxolone methyl (RTA 402) | Nrf2 Activator | MedChemExpress
Schematic image of potential mechanism by which bardoxolone methyl... | Download Scientific Diagram
Antioxidants | Free Full-Text | Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Pharmacodynamics of bardoxolone methyl. A, levels of NF- k B, cyclin... | Download Scientific Diagram
Bardoxolone methyl | 218600-53-4
Synthesis, Biological Evaluation, and Molecular Docking Study of 3-Amino and 3-Hydroxy-seco A Derivatives of α-Amyrin and 3-Epilupeol as Inhibitors of COX-2 Activity and NF-kB Activation | Journal of Natural Products
The chemical structure of bardoxolone methyl. | Download Scientific Diagram
Signaling pathways of chronic kidney diseases, implications for therapeutics | Signal Transduction and Targeted Therapy
Role of NF-κB, PI3K and AKT pathways in ASC-mediated... | Download Scientific Diagram
IKK Signaling | IkappaB Kinase
Can Activation of NRF2 Be a Strategy against COVID-19?: Trends in Pharmacological Sciences
CDDO-Me | Cell Signaling Technology
Figure 2 from Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties | Semantic Scholar
Molecules | Free Full-Text | Transcription Factors as Therapeutic Targets in Chronic Kidney Disease
Molecules | Free Full-Text | Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites | Journal of Medicinal Chemistry
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy
JCM | Free Full-Text | Inflammatory Targets in Diabetic Nephropathy
Bardoxolone methyl (RTA 402) | ≥99%(HPLC) | IκB/IKK inhibitor | AdooQ®
Bardoxolone conjugation enables targeted protein degradation of BRD4 | Scientific Reports
Increased albuminuria in bardoxolone methyl–treated type 2 diabetes patients: mere reflection of eGFR improvement? - ScienceDirect
reta-10k_20171231.htm
